The application basis of immuno-checkpoint inhibitors combined with chemotherapy in cancer treatment

Immuno-checkpoint inhibitors (ICIs) bring a promising prospect for patients with cancers, which restrains the growth of tumor cells by enhancing anti-tumor activity. Nevertheless, not all patients benefit from the administration of ICIs monotherapy. The partial response or resistance to ICIs is main...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Ming-Yan, Liu, Han-Ge, Chen, Xiao-Hong, Tian, Ye, Chen, Zhi-Nan, Wang, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871553/
https://www.ncbi.nlm.nih.gov/pubmed/36703971
http://dx.doi.org/10.3389/fimmu.2022.1088886

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871553/
https://www.ncbi.nlm.nih.gov/pubmed/36703971
http://dx.doi.org/10.3389/fimmu.2022.1088886

Ejemplares similares